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Abstract 
Osteopathic Manipulative Medicine (OMM) and Reduction of NSAID Use In Low Back 
Pain: A Pilot Study 
Kristopher Kelly 
MS Biomedical Sciences, May 2014 
Philadelphia College of Osteopathic Medicine 
Frederick Goldstein, Thesis Advisor 
 
 This randomized controlled pilot study is to determine if a combination of muscle 
energy and soft tissue techniques can reduce the amount of daily NSAID use in patients 
suffering from chronic non-specific low back pain (CNSLBP). Osteopathic manipulative 
treatment has been shown to be useful in treating low back pain. However, its role in 
reducing daily NSAID use in CNSLBP patients is unclear. This study was conducted at 
PCOM from January 2014 to April 2014. By design, patients were to be randomized into 
either a treatment group consisting of OMT or a control group consisting of a sham 
OMT. Of the two patients who were recruited, one met the eligibility criteria (n=1). This 
patient was randomized into the treatment group with OMT and was allowed to continue 
to take NSAIDs as needed to treat low back pain. The primary outcomes included a 
percent reduction in daily NSAID use and a percent reduction in daily pain scores from a 
11-point 10 log scale. As compared to the baseline data, the patient who received 
osteopathic manipulative treatment presented with an increasing trend in daily NSAID 
use and pain scores. The competitive soccer combined with the clear diagnosis of 
iliolumbar ligament strain can account for the continuous discomfort and somatic 
dysfunction. With only one patient, there was no comparison to sham manipulation. No 
conclusion can be made to address OMT reducing daily NSAID use and pain in patients 
suffering from CNSLBP with the limited amount of data we obtained from this study. 
Further assessment of the difficulty with clinical research was discussed.  
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Chapter 1. Introduction 
 
 Back pain is a major concern for the developed world. It affects men and women 
of all ages and causes an immense economic burden on individuals, families, 
communities, industries, and governments (Hoy et al, 2010).  Orrock (2013) described 
Low back pain (LBP) as a 21st century epidemic.  It is currently considered a public 
health problem, has a high rate of disability, and is the leading cause of activity limitation 
and absenteeism in the workforce throughout the world.  Approximately 75% of adults 
will experience LBP at least once in their life (Majid and Truumees, 2008).  It is 
estimated that approximately 15% to 20% of the U.S. population experiences LBP 
annually, and at any given time, 2% of the population is disabled due to back problems 
(Licciardone et al, 2003).  LBP is the most common condition cited by patients seeing a 
Doctor of Osteopathic Medicine (DO), accounting for approximately 11% of visits 
(Earley, 2010).  Also, LBP symptoms are the second leading reason for office visits to 
primary care physicians (Early, 2010). 
 
1.1 Epidemiological Parameters 
 
 Epidemiological studies on LBP consist of a substantial amount of heterogeneity 
limiting the amount of accurate data. In the most current systematic review Hoy et al 
(2010) found the 1-year incidence of a first-ever episode of LBP to range from 6.3% to 
15.4%, while the 1-year incidence of any episode of LBP to range from 1.5% to 36%.  
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Additionally, Hoy et al (2010) found the point prevalence to range from 1.0% to 58.1% 
and 1-year prevalence from 0.8% to 82.5%. 
 
1.2 Low Back Pain Anatomy 
 
 LBP encompasses both lumbar and sacral spinal regions.  Lumbar spinal pain is 
defined as pain perceived anywhere in the area bordered by the last thoracic spinous 
process, the first sacral spinous process, and the lateral borders of the erector spinae. 
Sacral spinal pain is defined as pain perceived anywhere in the area bordered by the first 
sacral spinous process, the posterior sacrococcygeal joints, and the posterior superior iliac 
spines. These borders define the area of pathology, but the pain is not restricted to these 
sites. Many experience discomfort in their lower limb, which is known as somatic 
referred pain; it is due to damaged structures sharing the same nerves and innervation 
(Bonica’s Encyclopedia, 2010). 
 
1.3 Low Back Pain Terminology 
 
 The length of illness is a necessary and important parameter to consider when 
managing LBP. Adjectives, such as acute, subacute, and chronic are used to describe the 
period of time LBP has been perceived. Acute pain is defined as pain of recent onset, 
subacute pain as lasting at least five to seven weeks but no longer than 12 weeks and, 
finally, chronic pain is defined as that lasting equal to or longer than three months 
(Bonica’s Encyclopedia, 2010). This study will be focusing on the latter.  
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 LBP can be classified as either specific or non-specific. Specific LBP has a 
known cause and some types of specific LBP are spondylolysis, spondylolisthesis, 
sacroiliac joint syndrome, lumbar spinal stenosis, lumbar disc herniation, etc. Non-
specific LBP has no known cause and will be the focus of this study.  
 
1.4 Sources of Low Back Pain 
 
 A majority of LBP patients have idiopathic pain. Although there are many 
potential sources of LBP, this study will be targeting somatic dysfunction. The idea is 
that people with mechanical LBP will have a loss of inter-segmental range of motion; 
restrictions that contribute to the mechanical etiology. This study is not trying to treat the 
LBP per se, but trying to resolve any somatic dysfunction that is impeding the ability to 
self-heal. There are four major types of somatic dysfunction and they consist of tissue-
texture changes, asymmetries, restrictions, and tissue tenderness.  
 
1.5 Low Back Pain Treatment  
 
 LBP has a plethora of treatment options that physicians recommend. The type of 
treatment for LBP is a decision that the individual, along with the treating physician, has 
to make. Treatments include, but are not limited to drug therapy (e.g. non-steroidal anti-
inflammatory drugs (NSAIDs), opioids, muscle relaxants), injections (e.g. corticosteroid), 
physical therapy, massage, and manual manipulation. Manual manipulation is the 
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treatment option this study will focus on and is the most contested intervention for 
chronic low back pain (CLBP) (Bonica’s Encyclopedia, 2010). 
 Manipulation offered by osteopathic physicians (DOs) is called Osteopathic 
Manipulative Treatment (OMT). Although NSAIDs are often solely used to treat LBP, 
taken on a daily basis they can cause adverse effects such as gastrointestinal irritation and 
subsequent ulcers, edema, and hypertension. Since OMT is known to reduce LBP, 
complimenting OMT with conventional NSAID treatment may reduce the need for 
continual use.  
  Since the number of DOs in the United States has been increasing at a higher rate 
than allopathic physicians, and considering LBP is the most common condition amongst 
patients seeing a DO, there is a need to continue evaluating the efficacy of OMT in 
reducing both LBP and daily NSAID use. Since osteopathic physicians offer 
conventional and complimentary therapy, they can reduce healthcare costs acquired by 
sending patients to separate manual medicine professionals and allopathic physicians. It 
is known that osteopathic physicians reduce hospital admissions, referrals, radiographs, 
and prescribing medications to patients with LBP (Earley, 2010).  
 
1.6 Osteopathic Manipulative Treatment 
 
 The philosophy of osteopathy focuses on treating the origin of disease rather than 
only treating the symptoms. It emphasizes that the musculoskeletal system is the primary 
machinery for life, and the whole body is interconnected. Osteopathic techniques address 
dysfunction in order to maintain the body’s homeostasis. Osteopathic manipulative 
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treatment is a modality commonly used by osteopathic physicians to complement 
conventional treatment for chronic low back pain patients.  
 Osteopathic manipulative treatment is direct care, which involves using the hands 
to diagnose, treat, and prevent somatic dysfunction. Somatic dysfunction can be defined 
as “Impaired or altered function of related components of the somatic system: skeletal, 
arthrodial, and myofascial structures, and their related vascular, lymphatic, and neural 
elements” (Clinical Guideline Subcommittee 2010). OMT can help persons of all ages 
and can be used to ease pain and promote healing. When applicable, OMT can 
supplement or even replace drug therapy (Earley and Luce, 2010).  
 
1.7 Preliminary Studies 
 
 Most people experience their first LBP episode at an early age and LBP 
frequently reoccurs throughout the adult life leading to chronic conditions (Jenkins, 
2002). These clinical problems lead to the greatest medical costs and explain why CLBP 
is the most commonly studied condition (Earley, 2010). Although, optimal treatment for 
patients with CLBP remains a challenge for osteopathic physicians, research has steadily 
increased in the last decade investigating OMT as a complimentary treatment.  
 A systematic review by Licciardone et al (2005) found six OMT trials studying 
the efficacy of OMT in reducing low back pain. The overall results distinctly showed a 
statistically significant (P <0.05) reduction in low back pain with OMT. Thus, 
Licciardone et al (2005) believed that OMT could possibly eliminate or reduce the need 
for analgesics.  
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 A randomized controlled trial (RCT) performed by Hoehler et al (1981), found 
that manipulation alleviates LBP when comparing manipulation with a placebo treatment. 
Also, an osteopathic study by Cleary and Fox (1994) found that OMT reduced 
menopausal symptoms, such as spinal ache and neurological irritation at the spinal level. 
Additionally, Anderson et al (1999) RCT found that daily use of NSAIDs and muscle 
relaxants were significantly (P <0.001) less in OMT patients compared to standard care 
patients. Finally, it has been reported that OMT plus usual care provided better one-
month outcomes in back pain and fewer cotreatments compared to usual care alone 
(licciardone et al, 2003) 
 A more recent systematic review by Orrock et al, (2013) included recent studies 
assessing the efficacy of OMT as a treatment modality for chronic non-specific low back 
pain (CNSLBP). CNSLBP is a diagnosis of exclusion. Physicians have to rule out pain 
caused by a suspicious or confirmed serious pathology (‘red flag’). Red flags are serious 
medical conditions and include, cancer, infections, fractures, or any other type of trauma 
that mimics mechanical LBP. Orrock et al (2013) found two trials that qualified for 
review, but both differed in their conclusions. The Licciardone et al (2003) investigation 
found that the OMT group was similar in effect to a sham group while Chown et al 
(2008) found that there was a similarity of OMT with exercise and physiotherapy.  
 Recently Licciardone et al (2013) published the Osteopathic Trial with results 
concluding that OMT significantly reduces CNSLBP with less frequent use of 
prescription drugs. The results showed that OMT was efficacious for short-term pain 
relief when it was used to compliment co-treatments for CNSLBP. This trial met the 
Cochrane Back Review Group criteria for a medium effect size for both moderate and 
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substantial improvements in LBP. Most importantly was the less frequent use of 
prescription drugs (i.e. NSAIDs) in OMT patients. These findings corroborate the clinical 
relevance for reduction in LBP. Further, this trial validates why most LBP patients are 
cited seeing an osteopathic physician and why a majority of the patients that osteopaths 
examine are suffering from LBP. Also, this trial justifies why osteopathic physicians 
prescribe less medications. OMT that reduces pain warrants a better prognosis without 
the need to take pain medication, such as NSAIDs.  
  In patients who underwent elective transabdominal hysterectomy, Goldstein et al (2005) showed a significant (p < 0.05) decrease in postoperative morphine use when OMT was employed in combination with pre-emptive morphine. Reductions in morphine use occurred at 24 and 48 hours after multiple OMT treatments compared to SHAM treatment (figures 1 and 2); in addition, at 48 hours morphine blood levels were lower (figure 3). 
Figure 1. First 24 hours after surgery (0-24 hours): total postoperative dose of morphine sulfate (mg/kg).  
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Figure 2. Second 24 hours after surgery (25-48 hours): total postoperative dose of morphine sulfate (mg/kg). 
 
  
Figure 3.  Twenty-four hours after surgery: patients’ postoperative morphine blood concentrations (ng/mL).    
    9   A recent study by Heymann et al (2013) investigated acute nonspecific LBP by comparing spinal manipulation to the NSAID drug dicoflenac. They found that the spinal manipulation group had significantly better pain outcomes than the dicoflenac (NSAID) group. Also, spinal manipulation proved to be more clinically efficacious than the placebo group. This study by Heymann et al motivated the design of this thesis. Since manipulation has a better efficacy than NSAIDs when treating nonspecific LBP, then complementing standard NSAID treatment with manipulation should decrease daily NSAID use in patients suffering from CNSLBP.   Finally, a retrospective observational study by Prinsen et al (2014) found that pain 
and medication use (analgesics, anti-inflammatory agents, muscle relaxants) is lower in 
patients who received OMT, which aligned with previous RCTs. Data were abstracted 
from medical records of families that participated in The American Osteopathic 
Association Clinical Assessment Program (AOA-CAP) between 2006 and 2007. These 
records revealed reduced use of analgesic medications, anti-inflammatories, and muscle 
relaxants, inferring that patients were in less pain. This study was a novel approach, but 
such results continue to solidify the fact that more research is needed to test OMT 
reducing NSAID use.  
 
1.8 Purpose of Study 
 
 The purpose of this pilot study is to determine if a combination of muscle energy 
and soft tissue techniques can specifically reduce the amount of daily NSAID use in 
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patients suffering from CNSLBP. Pre-treatment and post-treatment NSAID use will be 
documented on a daily pain and medication diary and compared to assess the efficacy of 
OMT in reducing daily NSAID use. Also, data will be recorded to determine if OMT 
reduces pain. Pre-treatment and post-treatment pain levels will be recorded and assessed.  
Additionally, evaluation will be of a standard protocol for treatment of CNSLBP. To the 
best of our knowledge, this is the first time that OMT has been deployed on CNSLBP 
patients to specifically assess a reduction in the amount of NSAIDs taken daily.  
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Chapter 2. Materials and Methods 
 
2.1 Project Approval 
 
 Philadelphia College of Osteopathic Medicine (PCOM) Institutional Review 
Board (IRB) approved this investigation and its consent form (Appendix A) on 
September 11, 2013. 
 
2.2 Personnel 
 
 Donald Allison, DO, performed OMT for the study at the PCOM Osteopathic 
Manipulative Medicine (OMM) department. 
 
2.3 Patient Recruitment 
 
 Dr. Allison recruited his new CNSLBP patients to be in this study. Patients were 
given a pain and medication diary (Appendix B) each week to assess pain and medication 
use. Additionally, patients needed to meet inclusion and exclusion criteria. 
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2.3.1 Inclusion Criteria 
 
Chronic low back pain ≥ 3 months 
Currently taking an NSAID to relieve pain 
OMT is appropriate therapy 
Eighteen years of age or older 
Patient: 
 able to self-report pain levels, 
 able to request medications, and 
 naïve to OMT 
 
2.3.2 Exclusion Criteria 
 
Current antidepressant therapy 
Current opioid use 
Concurrent manipulation (e.g. physical therapy, chiropractor, rolfing, acupuncture, 
acupressure, or massage therapy) 
Lumbar spinal surgery (e.g., fusion) 
Spinal stenosis 
Previous or current malignancies in lumbar-sacral region 
Previous diagnosis of Complex Regional Pain Syndrome (CRPS) 
Pregnancy 
Unable to maintain pain and medication diary 
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Unable to show up to scheduled appointments 
Unreliable transportation 
Involved in any medical malpractice litigation   
 
2.4 Patient Confidentiality 
 
 Signed consent documents and pain and medication diaries were kept in a locked 
file cabinet. Excel files are accessible only to study personnel and protected by passwords 
and access privileges. 
 
2.5 Experimental Design 
 
 Once patients were recruited, Dr. Allison was to discuss this study with the new 
patient. All potential patients were given a week to take home, read and share the consent 
form with any family members or friends. 
 
2.5.1 Pre-Treatment Evaluation  
 
 Dr. Allison was to determine if patients met all inclusion and exclusion criteria by 
asking compliancy questions, and performing a personal history and physical exam. 
2.5.1.1 Compliancy Questions 
Questions regarding compliancy were asked during the pre-treatment evaluation. 
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 They were:  
 1. Will you be able to maintain a daily pain and medication diary?  
 2. Will you be able to show up to scheduled appointments?  
 3. Will you have reliable transportation to get to and from PCOM?  
2.5.1.2 Health History Assessment  
 A verbal detailed health history was documented, obtaining demographic 
characteristics, lifestyle, past medical and surgical history, and medications.  
2.5.1.3 Physical Examination 
 Dr. Allison performed a physical examination on each patient to check reflexes 
and muscle strength; these data were recorded.  
 
2.5.2 Evaluation of Somatic Dysfunction  
 
 Somatic dysfunction was assessed after the physical examination. An osteopathic 
structural exam was performed for tissue texture change, asymmetry, restriction, and 
tenderness in the lumbar-sacral region. The somatic dysfunction found was documented. 
 
2.5.3 Phase 1 – Baseline 14 Days 
 
 Once patients were cleared and evaluated for somatic dysfunction, baseline data 
were obtained using a pain and medication diary. This information was obtained during 
the two weeks prior to initiation of OMT. Patients were given a pain and medication 
diary each week to fill out and return upon appointment. It was designed to record daily 
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pain levels from a 11-point 10 log scale and to document the amount of NSAIDs used per 
day. Additionally, patients documented any other pain reduction modalities for each day 
(e.g., ice pack, heat). Once a baseline was obtained over the two-week period, OMT 
began. 
 
2.5.4 Phase 2 – Treatment 28 Days  
 
 Patients were to be randomly assigned into one of two experimental groups after 
being cleared for the study. The treatment group consisted of two specific OMT 
techniques and the control group consisted of a sham OMT therapy. The control group, 
were to all receive standardized sham OMT and treatment group, were to all receive 
standardized OMT. 
2.5.4.1 Muscle Energy Technique 
1. Physician positions the patient to the restrictive barrier 
2. Patient pushes into the direction of the ease of motion against physicians’ 
resistance three to five times for three to five seconds 
3. Physician reassesses patient for symmetry 
2.5.4.2 Soft Tissue Technique 
1. Patients lie in the prone position 
2. Physician massages low back to loosen the muscles 
 
 These OMT techniques were chosen because they have shown to resolve somatic 
dysfunction, thereby the body’s ability to maintain homeostasis and enhance its innate 
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ability for self-healing. This is accomplished by restoring normal range of motion, 
reducing static asymmetries, restoring normal tissue texture, and decreasing tenderness. 
The idea is that people with mechanical LBP will have a loss of inter-segmental range of 
motion/restrictions, which are contributing to the mechanical etiology. The focus is to try 
to resolve any somatic dysfunction that is impeding their ability to self-heal.  
 The control group was to involve a sham therapy, which required being 
positioned similarly to the muscle energy and soft tissue techniques, but only provided 
pressure in the amount of the physician’s hands for 30 seconds and without movement.  
 Each group was to receive 8 treatments over the course of four weeks with two 
treatments per week. Treatments were all 15 minutes in length. Throughout this treatment 
phase, patients continued to receive weekly pain and medication diaries to continue 
documenting pain and medication levels for comparison.  
 
2.6 Data Organization 
  
 Daily NSAID use and pain scores were recorded on pain and medication diaries. 
These data were imported into an excel document for comparison. 
 
2.7 Data Analyses 
  
 Data will be analyzed and quantified by using percent reduction in medication and 
pain scores.  
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Chapter 3. Results 
  
 The flow of patients through the experiment is shown in figure 4. Altogether, one 
(50%) of the two persons who were recruited was randomized into the treatment group. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Flow of patients through trial. 
  
 Characteristics were of patient one: 24 years of age, male, Caucasian, back pain 
greater than three months with ibuprofen used as needed, and no comorbid conditions.  
  
 
Two Screened for Eligibility 
One dropped out due to not taking an NSAID to treat low back pain 
One Patient Randomized 
One Patient Allocated to OMT Group 0 Patients Allocated to Control Group  
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Table 1. A list of dysfunction and appropriate OMT 
 
Table 1 exhibits results of the osteopathic structural exam for the first two weeks 
(baseline). The patient presented with a right anterior innominate and outflare and had a 
decrease in sacral motion. These pelvic dysfunctions were treated with the standard 
muscle energy technique. The inferior paraspinal muscles exhibited a generalized 
hypertonicity that was treated with a soft tissue myofascial technique. 
Table 2. A list of dysfunction and appropriate OMT 
 
Table 2 represents results of the osteopathic structural exam for weeks three and 
four and the treatment phase had commenced at this point. During these two weeks of 
treatment, the patient still presented with all the same dysfunctions, but with an additional 
L 3-5 NSLRR.   
 
 
 
 
Osteopathic Structural Exam – Weeks 1+2 
Dysfunction OMT  
Right anterior innominate Muscle Energy 
Right outflare Muscle Energy 
 Sacral motion Muscle Energy 
Generalized paraspinal hypertonicity Soft Tissue 
Osteopathic Structural Exam – Weeks 3+4 
Dysfunction OMT 
Right anterior innominate Muscle Energy 
L 3-5 NSLRR Muscle Energy 
 Sacral motion Muscle Energy 
Restricted right sacral iliac joint Muscle Energy 
Generalized paraspinal hypertonicity Soft Tissue 
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Table 3. A list of dysfunction and appropriate OMT 
 
 Table 3 exhibits results from the osteopathic structural exam for the final two 
weeks (weeks five and six). After two weeks of treatment the patient began displaying a 
posterior left innominate with a left inflare. The patient was finally diagnosed with a 
tender left iliolumbar ligament. Once the study was complete, the patient began being 
treated for a left tender iliolumbar ligament. 
 
 
Figure 5. Percent change in daily NSAID use compared to baseline. Values presented are arithmetic 
averages. 
  
Figure 5 shows an increasing trend over time with regard to the amount of 
NSAIDs taken on a daily basis for low back pain. After obtaining a two-week baseline, 
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the following week (week three), when compared to the baseline showed a 25% reduction 
in daily Ibuprofen use. The next week (week four), it quickly rose by 50% compared to 
the baseline. Week five showed a 25% reduction in daily Ibuprofen use. Last, the final 
week (week six) showed an overall 12% increase in daily NSAID use from the start of 
the study to the end of the study. 
 
 
Figure 6. Percent change in daily pain scores compared to baseline. Values presented are arithmetic 
averages. 
 
Figure 6 demonstrates an increasing trend over time with regard to daily pain 
scores for low back pain. When compared to baseline data, week three presented an 
initial 58% reduction in daily pain. The following week (week four) exhibited a 10% 
increase in pain from a 2.6 to 2.9 on a 10-cm visual analog scale. The subsequent week 
(week five) showed a 4.5% reduction in pain compared to baseline. Finally, the last week 
(week six) displayed an overall 61% increase in pain from 2.6 to 4.2.  
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Chapter 4. Discussion 
 
 This pilot study is unique in being the first to address the efficacy of OMT in 
specifically reducing daily NSAID use in CNSLBP. The study was limited to a sample 
size of one patient in the treatment group and none in the sham control group. When the 
study commenced, a sample size of 20 was the goal. The rationale was to have ten 
treatment patients to compare with ten sham control patients.  
 Recruitment issues developed immediately after this study was approved by the 
IRB. The OMM administrative staff was not helpful to recruit new patients as planned. 
Recruitment then became the sole job of the physicians, which proved difficult. A total of 
two patients were recruited with only one completing the study. One patient withdrew 
due to no longer needing an NSAID to treat pain. Since there was only one treatment 
patient and nothing to compare it to, the results for this study were limited. 
 
4.1 The Patient 
 
 The patient was 24 years of age, male, took Ibuprofen as needed, and was an 
active soccer player. He presented with CNSLBP and was given an osteopathic structural 
exam. Asymmetries were noted in the lumbosacral region and generalized paraspinal 
hypertonicity. The physician noted the etiology of this patient’s LBP to be from an 
iliolumbar ligament strain that did not explicitly exclude him from the study. This 
diagnosis is usually not treated with a muscle energy technique and could have had better 
results with another OMT therapy. Our standard OMT could have been aggravating this 
    22
type of dysfunction. This is one of the issues with applying a standard OMT therapy to a 
wide-spectrum disorder like low back pain. There are many tissues and structures in the 
lumbosacral region that can present with somatic dysfunction and the type and location of 
dysfunction will dictate the kind of OMT used to treat.  
 For each successive treatment, the patient continued to present these dysfunctions 
throughout the study. He played soccer three days a week and between each treatment. 
This competitive activity combined with the clear diagnosis of iliolumbar ligament strain 
can account for the continuous discomfort and somatic dysfunction. If the patient 
abstained from all competitive sports during treatment, then the dysfunction could have 
been resolved by the OMT, and ultimately relieved the pain he was experiencing.  
 
4.2 Results 
 
 The data collected were reported as percent reduction. The original design would 
have had statistical analyses comparing the treatment group to the control group, but had 
to troubleshoot due to only one patient completing the study. An increasing trend in daily 
NSAID use for low back pain is shown in figure 5. Additionally, an increasing trend in 
daily pain scores for low back pain is shown in figure 6. 
 The overall increasing trend in Figure 5 confirms the null hypothesis that there 
will be no reduction in daily NSAID use. Baseline data were averaged and showed a 
daily NSAID use of 225 mg. The first week of treatment (week 3) showed promising 
results of a 25% reduction. This reduction could have been a placebo effect, where the 
patient initially thought he was getting better due to being touched by a physician. The 
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following week (week 4) showed a vast increase of 50%, which can be explained by 
muscle energy technique initially causing soreness due to the force the physician places 
on the body. On the other hand, this can be explained as the dysfunction getting worse 
due to the standard OMT being used. In week 5, the patient once again had a 25% 
reduction, which was initially thought to be the actual treatment working. This follows 
the pattern we were looking for, where there is an initial decrease, followed by an 
increase due to the force of muscle energy, and then a reduction due to structures 
returning to homeostasis. But, the final week the patient presented with a 12% increase 
from baseline suggesting an overall increase in daily NSAID use over the total six-week 
study. This increase in overall daily NSAID use can be translated into the patient being in 
more pain due to standard OMT aggravating the inflamed iliolumbar ligament. Also, the 
competitive soccer combined with this clear diagnosis of iliolumbar ligament strain can 
account for the continuous discomfort and somatic dysfunction. 
 The trend in figure 6 follows the same trend as figure 5. This increasing trend in 
daily pain scores over the six-week study period was expected to follow the same trend as 
daily NSAID use. This increase can be rationalized the same way. Once again this trend 
confirms the null hypothesis, that there will be no difference in daily pain scores. 
 Despite the unfavorable findings, it would be a leap to state that OMT, when 
complemented with standard low back pain therapy, does not benefit in decreasing low 
back pain or daily NSAID use. The data represented in figures 5 and 6 came from one 
patient and had no control to compare to. Additionally, the data is so limited due to the 
small sample size that a percent reduction from many patients would be needed to make 
an assumption about the OMT. Finally, since the patient presented with an inflamed 
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iliolumbar ligament that requires other OMT and possibly steroids, this patient’s data 
would not be accurate to use to assess daily NSAID reduction.   
 Previous studies have confirmed the benefit of pain reduction and consequently 
analgesic reduction when complementing standard low back pain therapy with OMT. 
Licciardone et al (2013) osteopathic trial investigated pain score reductions and other 
outcome differences between CNSLBP patients who received OMT versus a sham OMT. 
This study had a sample size of 455 and proved statistical significance in decreased pain 
scores over time and overall improvement with OMT compared to the sham OMT. This 
study clearly exhibits OMT benefiting patients with CNSLBP and pain reduction over 
time. Thus, our study would need a larger sample size and a better design in order to 
refute the benefits OMT has on CNSLBP patients.   
 
4.3 Limitations 
 
There were several limitations and factors that attenuated the potential benefit of 
OMT in this study.  First, the small sample size did not allow for sufficient amount of 
data to be gathered to confirm or refute the null hypothesis. The patient recruitment was 
originally planned to be from the OMM secretarial staff, but immediately after the study 
was approved the staff refused to recruit their new CNSLBP patients. Also, the study was 
not approved by the IRB until January 2014, which left only 4 months to recruit patients. 
Second, before the study commenced, there was difficulty homogenizing for type 
of NSAID to be used. It was difficult to decide on limiting the study to one NSAID or 
leave the door open to any NSAID. Accepting any NSAID into the study would have 
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created statistical entropy, so the decision was to select one. The drug selected was 
ibuprofen due to dosing purposes. Eliminating some of the most popular NSAIDs, such 
as naproxen had to occur because their dosing is once every 12-24 hours leaving only a 
few doses per day to analyze for a percent reduction. Another difficulty was if new 
patients were already taking naproxen because switching them to ibuprofen would 
increase the amount of pills per day compared to naproxen. This would be bad science 
and most likely contributed to the small sample size. 
Third, it was difficult to standardize OMT for CNSLBP patients. It was 
hypothesized that a muscle energy and soft tissue technique would be appropriate for 
patients suffering from CNSLBP. OMT for low back pain has a “treat what you find” 
method due to the vast amount of structures and dysfunctions in the lumbosacral region 
and one of the potential benefits would be to standardize a therapy specifically for LBP 
patients. Heymann et al (2013), found a significant pain decrease when applying high-
velocity low amplitude OMT technique compared to the NSAID diclofenac. Future 
research can be geared towards this technique rather than muscle energy and soft tissue 
techniques. Additionally, there was no OMT training for hand placement or time for the 
specific techniques the physicians used. The physicians seemed to be troubled and 
resistant to having a standard therapy for treating CNSLBP once the study began due to 
the vast heterogeneity in dysfunctions. 
Fourth, the control consisted of a sham OMT therapy. This is one of the many 
difficulties with OMM clinical research. Patients suffering from low back pain are 
randomized into a sham therapy, which is not a satisfactory control. Sham therapies are 
unsatisfactory because the patient will be touched in some form. Although the physician 
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will only apply pressure in the amount of their hands, pressure is still being applied 
potentially changing myofascial structures.  
 
4.4 Difficulties with Clinical Research 
 
Clinical research presents many difficulties and one of the major issues that 
attenuated our study was patient recruitment. A systematic review done by McDonald et 
al (2006) concluded that most clinical trials experience recruitment difficulties. This 
review showed that 41% of trials that begin to recruit are delayed and 63% exhibited 
early recruitment problems. Additionally, only 31% of trials reach their recruitment goal 
while 34% of trials have to revise recruitment targets mostly leading to worse outcomes. 
These issues with recruiting can be caused by researchers and clinicians tending to 
overestimate patient availability, indifferent project managers, and screening negligence. 
A factor that is associated with successful recruitment is having a dedicated principal 
investigator. 
Tramm et al (2013), found a majority of recruitment issues stemming from design 
flaws. Overestimation of available participants is one of the most common issues and is 
known as ‘Lasagna’s Law’. Specific recruitment strategies must be selected 
appropriately. At the top of the list for recruitment strategy is a flyer for clinical staff and 
patients (Tramm et al, 2013). Flyers are a great way of letting people know a study is 
actively taking place. Another strategy is employing extra staff (Tramm et al, 2013). 
Hiring a research coordinator can alleviate much stress from the secretarial staff and 
research team. A single person who is organized and dedicated to patient recruitment 
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would be much more professional. Finally, having a weekly investigator/recruitment 
meeting is a great strategy for improving patient recruitment (Tramm et al, 2013). 
Weekly meetings create more homogeneity for all the investigators and promote more 
initiative for obtaining patients.  
Another strategy for increasing patient recruitment is incentives (Tramm et al, 
2013). Rewarding the recruiting staff and patients is a great way for increasing sample 
size. It can promote better work ethic from the recruiting staff and also make them feel 
appreciated. Incenting the patients to be a part of a study will show they have value and 
meaning in the research. 
 
4.5 Difficulties with OMM Clinical Research 
 
In the recent past, research has not been a traditional component to the osteopathic 
profession but it is currently trying to change this (Earley, 2010). Although improvements 
in the amount and quality of osteopathic research have been achieved, there are still 
limitations dealing with blinding and sham manipulation. OMM clinical research follows 
the pharmacological research design of placebo and the double-blinded methodology. It 
is impossible to follow this double-blinded approach in OMM due to the physician 
employing a real OMT to some patients versus a sham OMT to others. Also, the placebo 
being a sham manipulation is hotly contested compared to a pharmacological placebo, 
since the physician will apply pressure to the underlying myofascial tissue potentially 
increasing the placebo affects. 
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4.6 Future Research 
 
Future research assessing the benefits of OMT on reducing daily NSAID use in 
CNSLBP patients requires a better design. Patient recruitment remains the priority since 
the study obtained only one patient. Although patient recruitment may seem simple, it has 
presented as a much more complex issue. It requires a group effort and an excellent 
strategy for obtaining and maintaining patients.  
The research team can benefit from weekly meetings discussing the current status 
and future directions of the project. Informing all parties will create a more professional 
and structured environment that future patients will notice. If a patient senses any lack of 
communication between the physicians and the research team they will be more likely to 
opt out of the study. Creating an environment that appears thorough and well organized 
will only enhance the amount of future patients for the study.  
One of the reasons why this study failed was due to other physicians not joining 
into this project. A collaborative effort with equal distribution is necessary. This study 
could have benefited from a research coordinator. Hiring a work-study student as a 
research coordinator would help immensely when it comes to recruiting patients. 
Frequent phone calls to patient referral sites and a direct line for patients to call about the 
study would create better logistics for obtaining patients. Also, including several post-
doctorial fellow students to perform the OMT would allow for a greater sample size. 
Once a team is formed, a collective effort into organizing an excellent logistical 
protocol for patient recruitment is required. In this study, logistical preparation for patient 
recruitment failed. Only new patients from one site were recruited. Multiple PCOM sites 
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would need to be informed personally and distribution of flyers to all these sites a 
priority. Including students at PCOM to be eligible for the study would also increase the 
sample size. A flyer could include the current study taking place and a number to call 
with designated hours to enroll or request information. 
Once patients are enrolled in the study, protected time for the post-doctorial 
fellow students and physicians would be needed. Setting time aside for certain days and 
hours to see patients will create a structured environment for the research team and 
patients. Again, a research coordinator would be valuable here for scheduling patients. 
Besides patient recruitment, the limiting exclusion criteria may have contributed 
to the small sample size. Patients were to be naïve to OMT, which limited us to only new 
patients. Not eliminating previous or current OMM patients from the study would most 
likely increase the sample size. Controlling the distribution of naïve to non-naïve patients 
would eliminate any significant difference between groups. Stratifying the groups if need 
be would reduce the randomization, but would be necessary to have a sufficient sample 
size.  
Finally, the post-doctorial fellows and physicians need to be trained on proper 
hand placement and timing for a standard OMT and sham OMT deployment. This 
training will assure each patient is receiving the same treatment between the treatment 
and control groups. Additionally, deciding whether the muscle energy and soft tissue 
techniques or the high-velocity low amplitude technique has better efficacy for LBP 
patients is required.   
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4.7 Conclusion 
 
In conclusion, with the limited amount of data we obtained from this study, there 
can be no assessment made about the benefits OMT have on reducing daily NSAID use 
and pain in patients suffering from CNSLBP. However, with a better recruitment 
strategy, logistics, and a less limiting exclusion criteria this study has great potential for 
benefiting those suffering from CNSLBP. 
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INFORMED CONSENT FORM 
TITLE OF STUDY 
Osteopathic Manipulative Medicine (OMM) and Reduction ofNSAID Use In Low Back Pain: A 
Pilot Study 
TITLE O:F STUDY IN LAY TERMS 
Does Osteopathic Manipulative Treatment (OM1) lower the amount of non-steroidal anti-
inflammatory drugs (NSAIDS) taken by patients having low back pain for 3 or more months. 
'PURPOSE 
The purpose of this research is to find out ifNSAID (pain reliever) use and pain can be reduced 
by using specific OMT techniques to treat chronic lower back pain. Also, we are trying to obtain 
a standard OMT therapy for low back pain patients. 
You are being asked to be in this research study because you presently have consistent lower 
back pain greater or equal to 3 months, you are currently taking an NSAID, such as ibuprofen, to 
relieve pain and OMT is an appropiate therapy for you. For you to be in this study, you must be 
18 years of age or older, able to self-report pain levels, able to request medications, have never 
had OMT as a treatment modality, and be willing to try osteopathic manipulative treatment as a 
modality to reduce pain and NSAID usage. If at any time you are unable to keep a pain diary or 
show up for scheduled appointments, or have unreliable transponaion you cannot be in this 
study. Similarly, if you are currently taken medicine for depression or narcotics, or receiving 
another type of manipulation (e.g. physical therapy, chiropractor, rolfmg, acupuncture, 
acupressure, or massage therapy) you cannot be in this study. Finally, if you had low-back 
surgery, have spinal stenosis, have or bad cancer in the lower back, have been diagnosed with 
complex regional pain syndrome (CRPS), are pregnant, or involved in any medical malpractice 
lawsuit, you can not be in this study. 
INVESTIGA TORCS) 
Principal Investigator: Dr. Donald Allison, 
DO 
01/10/14 
Co-Investigator: Frederick Goldstein, 
PhD,FCP 
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Philadelphia College of O~lt:opaLIJjc Mt:r.licine 
Department: Osteopathic Manipulative 
Medicine 
Address: 4 170 City Avenue 
Philadelphia, PA 19131 
Phone: 215-871 -6425 
Phnadelphia College of Osteopl!thic ~'le!ftcine 
lns'Jtutional Revklw Bos;d 
~Date:~ 
~no.te:~ 
Institution: Philadelphia College of 
Osteopathic Medicine 
Department: Bio-Medical Sciences 
Address: 4170 City Avenue 
Philadelphla,PA 19131 
Phone: 215-871-6859 
Responsible (Student) Investigator: Kristopher Kelly, B.S 
The treatment you are being asked to volunteer for is part of a research project. 
If you have questions about this research, you can call Dr. Allison at (215) 871-6425. 
If you have any questions or problems during the study, you can ask Dr. AIJisoo, who will be 
available during the entire study. If you want to know more about Dr. Allison's background, or 
the rights of research subjects, you can call the PCOM Research Compliance Specialist at (21 5) 
871-6782. 
DESCRIPTION OF THE PROCEDURES 
lfyou decide to be in this study, you will be asked to keep a daily pain and medicine diary, come 
to two appointments in the first two weeks to give information on pain and medicine use, and 
come to eight OMT appointments. The eight OMT appointments will be twice a week for the 
following four weeks. Please bring your pain/medicine diary to each of these visits. You should 
take pain medicine during the study as needed and record it in the pain/medicine diary. 
In this study, you will be asked to lie down on a treatment table where the physicians will 
perform massaging techniques as well as exercises where you will be asked to push against the 
physician's hands. 
If you meet the requirments to be in this study, you will be randomly assigned to either the 
treatment group or the sham group. 
The study will take about 30 minutes for each session. There will be 1 1 session(s) over the 
course of7 weeks, for a total of 6.5 hours (Including the time to ftll out daily pain/medication 
diary) of your time. 
01/ 10/ 14 Page 2 of5 
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Philadelphia College of Osteopathic Medl~lne 
POTENTIAL BENEFITS 
~::~  
Expiration Date: _if¥ 
You may be able to take less pain medication, which would also mean fewer possible side 
effects. You may have less pain. You may not oenefit from being in. this study. Other people in 
the future may benefit from what the researchers learn from the study. 
RISKS AND DISCOMFORTS 
You may have a minor ache in the area being touched by the doctors. The osteopathic 
manipulative treatment being used usually produces no side effects. 
ALTERNATIVES 
The other choice is to not be in this study. You can continue taking your daily N SAID to reduce 
pain, as needed. Y au can have OMT without being in the study. 
PAYMENT 
You will not be paid for being in tllis study. You will be given 8 free osteopathic manipulative 
treatments over a span of 4 weeks. 
CONFIDENTIALITY 
All information and records relating to your participation will be kept in a locked file. Only the 
researchers, members of the Institutional Review Board, and the U.S. Food and Drug 
Administration wiU be able to look at these records. If the results of this study are published, no 
names or other identifying information will be used. 
REASONS YOU MAY BETAKEN OUT OF THE STUDY WITHOUT YOUR CONSENT 
If health conditions occur that would make staying in the study possibly dangerous to you, or if 
other conditions occur that would damage you or your health, the researchers may take you out 
of this stu~y. 
In addition, the entire study may be stopped if dangerous risks or side effects occur in other 
people. 
01/ 10/14 Page 3 of5 
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1\"EW FINDINGS 
Phliada!phia Coll&ge of OstGO"',.athie Mediek~e 
lostltutional Review Board 
App.-ova!D!.Ie:~ 
~Data:~ 
If any new information develops that may affect your willingness to stay in this study, you will 
be told about it. 
INJURY 
If you arc injured as a result of this research study, you will be provided with immediate 
necessary care. 
However, you will not be reimbursed for care or receive other payment. PCOM will not be 
responsible for any of your bills, including any routine care under this program or reimbursement 
for any side effects that may occur as a result of this program. 
If you believe that you have suffered injury or illness in the course of this research, you should 
notify the PCOM Research Compliance Specialist at (215) 871 -6782. A review by a committee 
v.>ill be arranged to determine if the injury or illness is a result of your being in this research. 
You should also contact the PCOM Research Compliance Specialist if you believe that you have 
not been told enough about the risks, benefits, or other options, or that you are being pressured to 
stay in this study against your wishes. 
VOLUNTARY PARTICIPATION 
You may refuse to be in. this study. You voluntarily consent to be in this study with the 
understanding of the known possible effects or hazards that might occur during this study. Not 
all the possible effects of the study are known. 
You may leave t.his study at anv time. 
If you drop out of this study, there wi I I be no penalty or Joss of benefits to which you are entitled. 
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Institutional Review Soa.'"d 
Awrova!Date:~ 
Expi."l!li:Jo1 Date~  
I have had adequate time to read this fonn and I understand its contents. I have been given a 
copy for my personal records. 
I agree to be in this research study. 
Signature of Subject: ___ ______________ _ 
Date: __ 1 __ 1 _ _ Time: ___ __ AMIPM 
Signature of Investigator or Designee. _______________ _ 
(circle one) 
Date: __ !__ ! ___ _ Time: _ _____ .AMJPM 
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A RESEARCH STUDY TO REDUCE NSAID USE IN 
PATIENTS HAVING CONSISTENT LOW BACK PAIN 
PAIN AND MEDICATION DIARY- WEEK ONE 
YOU WILL GET A SEPARATE DIARY FOR EVERY WEEK 
If you have any questions or concerns about this research, please call the 
Principal Investigator for this study, Dr. Donald Allison, Assistant Professor, 
PCOM Department of Osteopathic Manipulative Medicine 4170 City Ave, Suite 
320 at 215-871-6425 
Bc~fore you turn to the next M£!e o/eqse answer these questions: 
DID ANYTHING HAPPEN TO YOU THIS WEEK THAT GAVE YOU MORE 
PAIN? FOR EXAMPLE, DID YOU FALL DOWN? 
PLEASE CHECK ONE: __ NO __ YES 
lF YOU CHECKED 'YES', PLEASE WRITE DOWN WHAT HAPPENED. 
Page 1 
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Please complete the following iriformation. 
Patient Name: 
Telephone Number(s): Home: Work: 
Date you started to write your information on this form: __________ _ 
WEEK 
ONE 
Day I 
Day2 
Day3 
Day4 
Day5 
Day6 
Day7 
How many NSAID 
tablets did you 
use today? 
0 2 
I have no pain 
How would you 
score your pain 
this morning? 
How would you 
score your pain 
this afternoon? 
Pain Scale 
3 4 5 6 7 
How would you 
score your pain 
tonight? 
8 9 
Use any other 
methods of pain 
relief (e.g. ice pack 
or heat) today? 
10 
I have the 
worst pain I 
ever had 
Date Completed: ________ _ 
After you complete this page, please bring it with you - in the envelope we gave you - to each of 
your visits at PCOM Rowland Hall, Suite 320. 
Thank you fOr choosing to be in our studv 
Page 2 
    42
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
